Computational Infrastructure Scientist – Biological Data Systems at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, PharmaceuticalsIndustries

Requirements

PhD in Computational Biology, Chemistry, Bioinformatics, or a related scientific field
Strong programming experience in Python and strong familiarity with R
Proficiency in Linux environments and Git (required)
Knowledge of biological databases, ontologies, and metadata systems
Knowledge in PostgreSQL databases
Exposure to cloud platforms (e.g., AWS S3, EC2, or equivalent)
Experience working with workflow execution environments including NextFlow
Experience developing data-driven decision support applications including data and visual analytical tools
Exposure to Docker or containerized environments
Strong communication skills and the ability to work independently on open-ended technical problems
Understanding of web design and API (preferred)

Responsibilities

Strategize and implement scientific data processing workflows that transform complex biological datasets into actionable insights
Design and develop innovative algorithms and ETL systems to address emerging challenges in biological and drug discovery data integration
Collaborate cross-functionally with domain scientists and engineers to translate biological questions into computational frameworks
Contribute to the long-term architecture and evolution of the data platform, ensuring scalability, transparency, and reproducibility
Develop cloud-based workflows and APIs that enable efficient access and analysis across diverse biological datasets
Document and share design decisions to promote reuse and institutional knowledge
Develop and extend data models and ontologies that harmonize heterogeneous sources of biological, genetic, and clinical information
Design scalable data ingestion, standardization, and transformation pipelines for genomic and functional datasets
Collaborate with domain experts in genomic medicine, computational biology, bioinformatics, genetics, and informatics to ensure that infrastructure design supports high-impact scientific use cases
Support and develop scientific workflows that impact the drug discovery portfolio
Build the frameworks that enable semantic interoperability, metadata-rich data exchange, and traceable, reproducible data workflows
Contribute to the evolution of open data standards and knowledge representation across the life sciences

Skills

bioinformatics

data architecture

software engineering

data models

ontologies

data ingestion

data pipelines

genomic data

scientific workflows

genetics

informatics

computational biology

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free